A phase 2b, randomized, double‐blind, multicenter, vehicle‐controlled study to assess the efficacy and safety of two crisaborole regimens in Japanese patients aged 2 years and older with mild‐to‐moderate atopic dermatitis

Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by pruritus, xerosis, and eczematous lesions. In Japan, treatment options, such as topical corticosteroids and tacrolimus, are associated with efficacy and safety concerns. Crisaborole ointment, 2%, is a topical non‐steroida...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujita, Kayo, Yagi, Michio, Moriwaki, Shinichi, Yoshida, Mizuki, Graham, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292399/
https://www.ncbi.nlm.nih.gov/pubmed/34435694
http://dx.doi.org/10.1111/1346-8138.16120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292399/
https://www.ncbi.nlm.nih.gov/pubmed/34435694
http://dx.doi.org/10.1111/1346-8138.16120

Ejemplares similares